BioScience Health Innovations, Inc.
corporate_fare Company Profile
BioScience Health Innovations, Inc. (OTC:BHIC) is a publicly traded company in the Technology sector. Wiseek has independently scored 6 items for BHIC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for BHIC spans 10-Q, 1-A POS, 10-K.
Recent high-impact activity:
- BHIC Discloses Ineffective Controls and Material Weaknesses as Nine-Month Loss Hits $565K
- BHIC to Buy Vitalcore and 40% Platform Stake for 450,000 Restricted Shares
- BioScience Health Swings to a Loss as Revenue Drops 41% and Cash Burn Accelerates
- BioScience Health Innovations Amends Offering, Raises Price to $4.50/Share for $5.0M Capital Raise
- BioScience Health Innovations Reports Q1 Loss, Negative Operating Cash Flow, and Material Internal Control Weaknesses
Financial Snapshot
Short Interest & Short Volume
On November 20, 2026, 73.4% of BHIC volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for BHIC, detected from its recent SEC filings · based on capital-structure filings through 2026-07-06.
Offering Price Increased Significantly · Substantial Capital Raise
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →